Schedule 13D ownership disclosure
Cannabics Pharmaceuticals Inc.
Security class unavailable · CUSIP: 13764M100
Event date: Unavailable
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 20,500,000
- Percent of class
- 51.0000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001019687-14-002550
- Form type
- SC 13D
- Filer
- Cannabics Inc.
- CIK
- CIK 1611611
- Filed
- Jun 25, 2014
- Reporting period
- —
- Description
- Schedule 13D beneficial ownership